Artisan Bio Star-CRISPR

Artisan Bio this week launched what it calls a "CRISPR-based one-stop shop" based on its Star-CRISPR platform for the research and commercialization of cell and gene therapies. Star-CRISPR includes a proprietary nuclease and guiding architecture, and its performance has been validated in T, NK, and iPS cells, with high gene knock-in and knock-out efficiencies, multiplexed editing capabilities, and large payload deliveries, the company said.